-
Nucleotide DNA polymerase inhibitor MIV-818 for liver cancer, awarded orphan drug title by the European Union
Time of Update: 2020-07-14
Medivir AB announced that the European Commission, in accordance with the advice of the European Agency for drug Management (EMA), has granted orphan drug products the designation of MIV-818 for t
-
Hematol Oncol: Differential expression of estrogen receptor-alpha in follicle tree cells in patients with level 1-2 and level 3 follicular lymphoma
Time of Update: 2020-07-14
Hormone therapy has been used in patients with estrogen receptor alpha (ER alpha) positive breast cancer Recently, a number of studies have reported on the expression of ER alpha in tumor cells B
-
Effect of IDH mutation on survival prognosis in patients with high-level meningioma
Time of Update: 2020-07-14
Meningia tumor is a common central nervous system tumor with an annual incidence rate of 8.3 per 100,000, of which 80%-90% of meningioma is a low-grade brain tumor with a recurrence rate of 7%-20% Rec
-
Brit J Cancer: Seropositive with Helicobacter pylori and hepatobiliary cancer
Time of Update: 2020-07-14
Studies have shown that Helicobacter pylori may play a role in hepatitis, gallstones and liver and bile tumors In a recent study published in the journal British Journal of Cancer, researchers aimed
-
Lancet: The Lancet new article consolidates the status of aspirin "god medicine" and can reduce the risk of colorectal cancer in two years
Time of Update: 2020-07-14
In scientific research, there is never a shortage of "myths" about aspirin Since its birth more than 100 years ago, researchers have been trying to apply the magic drug to prevention and treatment
-
Gynecol Oncol: Phase I study of newly diagnosed ovarian cancer, primary peritoneal cancer and intra-abdominal platinum chemotherapy combined with Veliparib and Beivaczumab
Time of Update: 2020-07-14
Improvements in epithelial ovarian cancer , peritoneal cancer or eOC disease-free survival can only be achieved through improved primary treatment Adding polyADP-ribonucleic inhibitors (PARPi) to a
-
Professor Yao Shuzhong: First-line maintenance of PARP inhibitors to maintain therapy biomarkers from BRCA to HRD plus, HRD Score testing helps screening of people benefiting from ovarian cancer
Time of Update: 2020-07-14
With the progress of PARP inhibitor research, the the path of of ovarian cancer is expanding Especially in the first-line maintenance treatment approved by the FDA , from Olapa's use of BRCA muta
-
Clin Cancer Research: Qumetinib Joint 5-FU CRT For Advanced Rectal Cancer
Time of Update: 2020-07-14
BACKGROUND: The RAS/RAF/MEK/ERK signaling pathway is critical to the development of colorectal cancer , and KRAS, NRAS, and BRAF mutations drive tumor tolerance to radiation therapy This study is a
-
China integrates tumor electric field treatment into standard program International cutting-edge innovative therapy for patients with glioblastoma
Time of Update: 2020-07-14
Qin Zhiyong said that the clinical prognosis of glioblastoma patients is very poor "Surgery plus chemotherapy and tumor electric field therapy" will become a new standard treatment plan. Chen Jing
-
Nature: A Review of Cancer Cell Treatment Targets
Time of Update: 2020-07-14
The largest number of the rapandatives in the field of immunology are cell therapy In an article published on May 26th, reviewnature dating: the clinical landscape trial, the authors provide the l
-
Nature Cancer: The incidence of colorectal cancer is closely linked to gut microbes
Time of Update: 2020-07-14
A joint study by researchers from the VIB-UGent Center for Inflammation Research and the University of The ate reveals a new mechanism that causes colorectal cancer The researchers found that abnorm
-
Large-scale prospective research analysis shows that if you quit smoking, limit alcohol and eat more garlic, you will not have stomach cancer. You have the final say!
Time of Update: 2020-07-14
There is a place in Shandong called Linyi County The place is small, with only 1,833 square kilometers, about one-tenth of Beijing's However, in the study of cancer in China, Linyi County is very fa
-
Clin Cancer Research: Autophagy inhibitor hydroxychloroquine combined with gisitabin/nab yew alcohol as a preoperative treatment for pancreatic cancer
Time of Update: 2020-07-14
BACKGROUND: Herbert J Zeh et al speculated that autophagy inhibition or enhanced response to chemotherapy in patients with pancreatic cancer , and conducted a randomized controlled trial to evaluat
-
PD-L1 monoanti-Bavencio: under review in Europe to treat metastatic urinary skin cancer
Time of Update: 2020-07-14
The European Drug Administration is reviewing Merck and Pfizer's PD-L1 monoanti-Bavencio (avelumab) for first-line maintenance treatment for patients with locally advanced or metastatic urinary sk
-
Guangdong issues first prescription for cancer electric field treatment
Time of Update: 2020-07-14
Guangdong issued the first prescription for the treatment of cancer electric field Zhong Xin Xinhua Guangzhou, June 30 (Cai Minxuan) Zhongshan University Cancer Prevention and Control Center on t
-
CELL: A New Strategy for Tumor Diagnostic Treatment: Metabolic Detection plus Dietary Treatment
Time of Update: 2020-07-14
Tumor transformation is associated with profound changes in cellular metabolism, but it is largely unknown whether tracking these can improve disease stratification or affect treatment decisions r
-
Application for a new drug for the treatment of hepatocellular carcinoma in PD-1 monoanti-Tisleizumab in Baiji Shenzhou was accepted by NMPA, as well as a summary of Tislelizumab clinical studies
Time of Update: 2020-07-14
Baiji Shenzhou announced that China's National Drug Supervision Management Bureau (NMPA) Drug Evaluation Center (CDE) has accepted Baiji Shenzhou's anti-PD-1 monoanti-retinzumab supplementation dr
-
Lancet oncol: ATR inhibitors in combination with gisythabin can prolong the non-progressive survival of patients with high-level slurry ovarian cancer with platinum resistance
Time of Update: 2020-07-14
Highly slurry-based ovarian cancer show increased replication pressure, sensitivity to ATR inhibition (due to near-universal loss of G1/S checkpoints due to the "TP53 harmful mutation"), premature
-
Summary of recent important original studies of colorectal cancer
Time of Update: 2020-07-14
The increase in the incidence of colorectal cancer among young people is related to an increase in surgical excision in obese patients there is currently a lack of national studies to test t
-
JAMA Surg: Cyan green lung targeted inhalation vs intravenous injection for lung cancer tumor edge identification
Time of Update: 2020-07-14
The recognition of tumor edges in surgery is very important for tumor removal, and intravenous indigoma (ICG) has some limitations in lung cancer excision Recently, researchers examined the clinical